PAREXEL ® INFORMATICS UTILIZING MEDICAL IMAGING IN CHRONIC LYMPHOCYTIC LEUKEMIA BREAKTHROUGH TRIAL Situation The pivotal Phase III CLL11 trial, conducted in cooperation with the German CLL Study Group (GCLLSG), was a multicentre, open-label, randomized three-arm study investigating the efficacy and safety profile of either Gazyva plus chlorambucil or MabThera/Rituxan plus chlorambucil compared to chlorambucil alone in 781 previo

Join for free to read